Redeye revises its financial forecast and valuation of Polygiene following the change of lead analys...
Synthetic MR:s förseningar i lanseringen av SyMRI 3D har lett till ett svagt första kvartal 2025, me...
Investors House has sold its 2/3 stake in JV Apitare to Nordisk Renting Oy and the minority owner Ov...
Nettoomsättningen för det första kvartalet uppgick till 4,6 (3,5) miljoner kronor.
Administer announced that it intends to acquire the financial, payroll and software services busines...
Adjusting the organisation, at cost of top line and near-term earnings Expect Q2-Q3 headwinds; we cu...
Redsense växer stabilt med stigande omsättning och förbereder lansering av Clamp i Storbritannien.
Q-linea provides a business update before closing and reports its Q2 result later in July.
Alisa Bank issued a profit warning, with continued weaker demand driving lower volumes.
Biovica continues to increase 12m rolling IVD test sales in Q4 of SEK 0.
Hansa Biopharma intends to carry out a 10m Directed share issue executed by an accelerated book buil...
Redeye comments on the topline data from the phase II study POSITANO, which investigates the effect ...
Key milestone for readiness Prolight has reported positive interim results from the ongoing patient ...
Redeye comments on Cantargia’s loan agreement with Fenja, which is positive in that it strengthens i...
